I reduced a cognitive decline marker by 36% using HBOT and sauna. Serum pTAU217 is a marke

Well SupportedSauna use 4-7 times per week is associated with a 66% lower risk of dementia and a 65% lower risk of Alzheimer's disease.

Well SupportedpTau217 and Aβ42 are FDA-approved biomarkers for Alzheimer's detection in symptomatic patients and can predict future dementia risk in healthy individuals.

Well SupportedElevated blood p-Tau217 levels in healthy individuals may warrant further brain imaging for Alzheimer's risk assessment.

Well SupportedHyperbaric oxygen therapy can improve cognition and reduce the risk of cognitive decline by enhancing attention, information processing, and brain blood flow.

Partially Supported